Cigarette smoking and subtypes of bladder cancer. 2012

Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. xuejuanj@usc.edu

There is little information regarding associations between suspected bladder cancer risk factors and tumor subtypes at diagnosis. Some, but not all, studies have found that bladder cancer among smokers is often more invasive than it is among nonsmokers. This population-based case-control study was conducted in Los Angeles, California, involving 1,586 bladder cancer patients and their individually matched controls. Logistic regression was used to conduct separate analyses according to tumor subtypes defined by stage and grade. Cigarette smoking increased risk of both superficial and invasive bladder cancer, but the more advanced the stage, the stronger the effect. The odds ratios associated with regular smokers were 2.2 (95% confidence intervals, 1.8-2.8), 2.7 (2.1-3.6) and 3.7 (2.5-5.5) for low-grade superficial, high-grade superficial and invasive tumors respectively. This pattern was consistently observed regardless of the smoking exposure index under examination. Women had higher risk of invasive bladder cancer than men even they smoked comparable amount of cigarettes as men. There was no gender difference in the association between smoking and risk of low-grade superficial bladder cancer. The heterogeneous effect of cigarette smoking was attenuated among heavy users of NSAIDs. Our results indicate that cigarette smoking was more strongly associated with increased risk of invasive bladder cancer than with low-grade superficial bladder cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012727 Sex Characteristics Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction. Gender Characteristics,Gender Differences,Gender Dimorphism,Sex Differences,Sex Dimorphism,Sexual Dichromatism,Sexual Dimorphism,Characteristic, Gender,Characteristic, Sex,Dichromatism, Sexual,Dichromatisms, Sexual,Difference, Sex,Dimorphism, Gender,Dimorphism, Sex,Dimorphism, Sexual,Gender Characteristic,Gender Difference,Gender Dimorphisms,Sex Characteristic,Sex Difference,Sex Dimorphisms,Sexual Dichromatisms,Sexual Dimorphisms
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits

Related Publications

Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
January 1990, European journal of cancer (Oxford, England : 1990),
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
December 1965, Virginia medical monthly,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
August 1965, JAMA,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
February 1985, Cancer letters,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
November 1976, British medical journal,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
March 1977, British medical journal,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
November 1971, American journal of epidemiology,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
June 2011, Carcinogenesis,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
August 1988, Cancer research,
Xuejuan Jiang, and J Esteban Castelao, and Jian-Min Yuan, and Mariana C Stern, and David V Conti, and Victoria K Cortessis, and Malcolm C Pike, and Manuela Gago-Dominguez
July 2010, Journal of the National Cancer Institute,
Copied contents to your clipboard!